Alpha-2b recombinant interferon (Intron-A) as maintenance treatment in multiple myeloma. 1990

G Avvisati, and M T Petrucci, and A Pulsoni, and M Tribalto, and V M Lauta, and A Gernone, and M Boccadoro, and F Marmont, and A Pileri, and F Dammacco
Department of Human Biopathology, University La Sapienza, Rome, Italy.

UI MeSH Term Description Entries
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077190 Interferon alpha-2 Alpha interferon encoded by the human IFNA2 gene. Recombinant forms are used in the treatment of CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; KAPOSI SARCOMA; MELANOMA; and HAIRY CELL LEUKEMIA. IFN-alpha 2,IFN-alpha-2,IFNalpha-2b, Recombinant,Interferon alfa-2a,Interferon alfa-2b,Interferon alpha-2b, Recombinant,Interferon alpha-A,Interferon-alpha 2,Intron A (Interferon),LeIF A,Reaferon,Recombinant Interferon alpha-2a,Recombinant Interferon alpha-2b,Ro 22-8181,Roferon-A,Sch-30500,Viferon,IFNalpha 2b, Recombinant,Interferon alfa 2a,Interferon alfa 2b,Interferon alpha 2,Interferon alpha 2b, Recombinant,Interferon alpha A,Interferon alpha-2a, Recombinant,Recombinant IFNalpha-2b,Recombinant Interferon alpha 2a,Recombinant Interferon alpha 2b,Ro 22 8181,Ro 228181,Roferon A,RoferonA,Sch 30500,Sch30500
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D016898 Interferon-alpha One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways. Interferon Alfa,Interferon, Leukocyte,Interferon, Lymphoblast,alpha-Interferon,IFN-alpha D,IFN-alpha5,Interferon alpha-1,Interferon alpha-17,Interferon alpha-4,Interferon alpha-5,Interferon alpha-7,Interferon alpha-88,Interferon alpha-J,Interferon alpha-T,Interferon alpha4,Interferon alpha5,Interferon, Lymphoblastoid,Interferon, alpha,LeIF I,LeIF J,Leif D,IFN alpha D,IFN alpha5,Interferon alpha,Interferon alpha 1,Interferon alpha 17,Interferon alpha 4,Interferon alpha 5,Interferon alpha 7,Interferon alpha 88,Interferon alpha J,Interferon alpha T,Leukocyte Interferon,Lymphoblast Interferon,Lymphoblastoid Interferon,alpha Interferon

Related Publications

G Avvisati, and M T Petrucci, and A Pulsoni, and M Tribalto, and V M Lauta, and A Gernone, and M Boccadoro, and F Marmont, and A Pileri, and F Dammacco
August 1992, European journal of haematology,
G Avvisati, and M T Petrucci, and A Pulsoni, and M Tribalto, and V M Lauta, and A Gernone, and M Boccadoro, and F Marmont, and A Pileri, and F Dammacco
January 1990, European journal of haematology. Supplementum,
G Avvisati, and M T Petrucci, and A Pulsoni, and M Tribalto, and V M Lauta, and A Gernone, and M Boccadoro, and F Marmont, and A Pileri, and F Dammacco
August 1991, Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates,
G Avvisati, and M T Petrucci, and A Pulsoni, and M Tribalto, and V M Lauta, and A Gernone, and M Boccadoro, and F Marmont, and A Pileri, and F Dammacco
February 1986, Blood,
G Avvisati, and M T Petrucci, and A Pulsoni, and M Tribalto, and V M Lauta, and A Gernone, and M Boccadoro, and F Marmont, and A Pileri, and F Dammacco
October 1994, British journal of cancer,
G Avvisati, and M T Petrucci, and A Pulsoni, and M Tribalto, and V M Lauta, and A Gernone, and M Boccadoro, and F Marmont, and A Pileri, and F Dammacco
January 1994, Acta haematologica,
G Avvisati, and M T Petrucci, and A Pulsoni, and M Tribalto, and V M Lauta, and A Gernone, and M Boccadoro, and F Marmont, and A Pileri, and F Dammacco
April 2005, Annals of oncology : official journal of the European Society for Medical Oncology,
G Avvisati, and M T Petrucci, and A Pulsoni, and M Tribalto, and V M Lauta, and A Gernone, and M Boccadoro, and F Marmont, and A Pileri, and F Dammacco
December 2005, Annals of oncology : official journal of the European Society for Medical Oncology,
G Avvisati, and M T Petrucci, and A Pulsoni, and M Tribalto, and V M Lauta, and A Gernone, and M Boccadoro, and F Marmont, and A Pileri, and F Dammacco
January 1990, Journal of internal medicine,
G Avvisati, and M T Petrucci, and A Pulsoni, and M Tribalto, and V M Lauta, and A Gernone, and M Boccadoro, and F Marmont, and A Pileri, and F Dammacco
December 1990, Indian journal of cancer,
Copied contents to your clipboard!